Lead optimisation of OXS007417: in vivo PK profile and hERG liability modulation to optimise a small molecule differentiation agent for the potential treatment of Acute Myeloid Leukaemia

Supporters

Support the authors with ResearchCoin

Tip RSC

Journal

RSC Medicinal Chemistry

Topics

Biology

Biochemistry

Chemistry

Medicine

Internal Medicine

Show all topics

DOI

10.1039/d4md00275j

License

CC-BY

Other Formats

PDF